LobbyingTeva Pharmaceuticals USA lobbying by quarter
Teva Pharmaceuticals USA's latest lobbying report covers Q3 2026, at under $5,000. The four quarters Q4 2025–Q3 2026 total $2.9M. Its first report covers Q3 2022; the issues it reports most are Health Issues and Medicare/Medicaid.
Teva Pharmaceuticals USA
- Latest quarter
- $0
- Q3 2026 · 1 reports
- Last 12 months
- $2.9M
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2022 | $830K | 1 |
| Q4 2022 | $700K | 4 |
| Q1 2023 | $340K | 4 |
| Q2 2023 | $1.4M | 3 |
| Q3 2023 | $360K | 2 |
| Q4 2023 | $310K | 2 |
| Q1 2024 | $1.4M | 2 |
| Q2 2024 | $360K | 4 |
| Q3 2024 | $470K | 4 |
| Q4 2024 | $490K | 4 |
| Q1 2025 | $430K | 3 |
| Q2 2025 | $1.5M | 3 |
| Q3 2025 | $620K | 4 |
| Q4 2025 | $740K | 5 |
| Q1 2026 | $1.5M | 5 |
| Q2 2026 | $600K | 5 |
| Q3 2026 | $0 | 1 |
By issue
- Health issues$8.4M · 45 reports
- Tariffs$2M · 6 reports
- Pharmacy$455K · 12 reports
- Medicare and Medicaid$320K · 15 reports
- Copyright, patent and trademark$250K · 8 reports
- Manufacturing$225K · 2 reports
- Trade$120K · 6 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- SENATE45 reports
- HOUSE OF REPRESENTATIVES42 reports
- Health & Human Services, Dept of (HHS)20 reports
- Centers For Medicare and Medicaid Services (CMS)17 reports
- Executive Office of the President (EOP)16 reports
- Food & Drug Administration (FDA)16 reports
- Commerce, Dept of (DOC)11 reports
- Homeland Security, Dept of (DHS)10 reports
- U.S. Trade Representative (USTR)6 reports
- White House Office1 reports
Firms it paid
| Firm | ||
|---|---|---|
| In-houseTeva Pharmaceuticals USA | $9.7M | 16 quarters |
| Capitol Hill Consulting Group | $900K | 15 quarters |
| MR. David Friedman | $550K | 3 quarters |
| Faegre Drinker Biddle & Reath | $520K | 9 quarters |
| Talley Strategies | $160K | 5 quarters |
| Polsinelli PC | $110K | 3 quarters |
| The Smith-Free Group | $80K | 2 quarters |
| Colas & Associates | $60K | 3 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BRIAN SUTTER | Staff Dir. W&M Health subcommittee, Chairman Dave Camp April'13-Dec'14. Professional Staff, W&M Health subcommittee, Chairman Dave Camp, Jan'11-April'13. Leg Dir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep Dave Camp, Feb'03-May'08. Staff Ast July'02 | Q2 2026 |
| CHRISTOPHER DAVIS | Staff Assistant, Legislative Assistant, Senior Legislative Assistant, and Legislative Director - Rep. Rick Boucher(2006-2011). | Q2 2026 |
| ELLIOT VICE | Staff Assistant, Legislative Correspondent & Scheduler, Sen. Evan Bayh (D-IN) 2009-2010 | Q2 2026 |
| EMILY ELIZABETH WILKINSON-HOLLAND | Staff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen. Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017),Sr Advisor to Administrator - Ctrs for Medicare & Medicaid(8/17- 5/19) | Q2 2026 |
| KIMBERLEE TRZECIAK | FDA. Dep. Commissioner; 8/23-1/25. Assoc. Commissioner Leg. Affairs; 2/2022-08/2023. House Com. Energy & Commerce: Chief Health Advisor, 2/22-4/19. Sen. Health Policy Advisor, 3/19-3/15. Rep. John D. Dingell - LD, 05/13-07/11. Sen. LA, 7/11-08/09, LA | Q2 2026 |
| MEGAN SUSSMAN HERBER | Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Doris Matsui (D-CA) 2014-2018 | Q2 2026 |
| DAVID FRIEDMAN | U.S. Amb. to Israel 2017-2021 | Q4 2025 |
| AMBER TALLEY | Senior Counsel/Investigator, Senate Special Committee on Aging; Legislative Director, Chief of Staff, Rep. Jason Chaffetz; Counsel, House Oversight Committee | Q3 2025 |
| BRYAN MICHAEL ALLEN | Staff Assistant, Legislative Correspondent, Legislative Aide, Sen. Susan Collins (R-ME) | Q2 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 09/04for Q3 | Talley Strategies | Under $5,000 |
| 07/20for Q2 | Talley Strategies | Under $5,000 |
| 07/20for Q2 | Capitol Hill Consulting Group | $60K |
| 07/20for Q2 | Faegre Drinker Biddle & Reath | $60K |
| 07/17for Q2 | MR. David Friedman | $100K |
| 07/17for Q2 | In-house | $380K |
| 04/21for Q1 | Capitol Hill Consulting Group | $60K |
| 04/21for Q1 | Talley Strategies | $60K |
| 04/20for Q1 | MR. David Friedman | $250K |
| 04/20for Q1 | In-house | $1.1M |
| 04/16for Q1 | Faegre Drinker Biddle & Reath | $60K |
| 01/20for Q4 2025 | Talley Strategies | $60K |
| 01/20for Q4 2025 | Capitol Hill Consulting Group | $60K |
| 01/19for Q4 2025 | Faegre Drinker Biddle & Reath | $60K |
| 01/15for Q4 2025 | MR. David Friedman | $200K |
| 01/14for Q4 2025 | In-house | $360K |
| 25/12/17for Q4 2025 | MR. David Friedman | Under $5,000 |
| 25/10/20for Q3 2025 | Talley Strategies | $40K |
| 25/10/19for Q3 2025 | Capitol Hill Consulting Group | $60K |
| 25/10/17for Q3 2025 | Faegre Drinker Biddle & Reath | $60K |